title: Characteristics, therapies, and factors influencing outcomes of hospitalized hypernatremic geriatric patients.
abstract: OBJECTIVE
  Hypernatremia is a common electrolyte disorder associated with adverse outcomes such as increased length of stay and mortality due to a variety of factors. Our aim was to investigate known factors as well as other variables which we had identified in hospitalized hypernatremic geriatric patients and their relationship to patient outcomes.
  
  
  METHODS
  A retrospective chart review of all adult hospitalized patients in a 4-month period with a serum sodium level >150 mmol/L was performed. Factors evaluated included use of a nephrology consultation, certain urine laboratory measures, fluids employed, rate of correction, and patient's level of care setting. Outcome measures included length of stay and mortality.
  
  
  RESULTS
  The patient mortality rate was 52 %. Mean age was 79.6 years (n = 33), and mean initial sodium level was 152.6 mmol/L. Plasma and urine osmolality, and urine sodium concentration were checked in less than 25 % of patients. Fifteen of 18 patients in the ICU expired, whereas only 2 of 15 patients not in the ICU expired (p < 0.0004, OR 32.50, CI 95 % (4.68-225.54)). Of the 23 patients (70 %) who had their serum sodium level corrected, 11 were corrected in ≤3 days and 12 in >3 days, but this difference did not affect mortality rate (45 vs. 50 %, p = 0.99). The mortality rate was similar (60 %, p = 0.52) for those whose serum sodium level never corrected suggesting that correction did not influence outcomes. The fluids chosen for therapy of the hypernatremia were appropriate to the patients volume status. Five of 15 patients who received a nephrology consultation survived, while 11 of 18 patients without a nephrology consultation survived (p = 0.12). The mean length of stay was 25.0 ± 23.9 days and no different for those who expired versus those who survived (25.2 ± 21.2 vs. 24.8 ± 25.9 days, p = 0.96).
  
  
  CONCLUSIONS
  Hypernatremia is associated with a poor prognosis, and outcomes are still disappointing despite appropriate rates of correction, intensive monitoring, and the involvement of a nephrologist. Strategies directed at avoidance of the development of hypernatremia and attention to concomitant disease may provide significant patient benefit.
authors.affiliation: Nephrology, Lenox Hill Hospital, 100 East 77th Street, New York, NY, 10075, USA, drtoor4@hotmail.com.
authors.forename: Muhammad R
authors.initials: MR
authors.lastname: Toor
authors.forename: Anjali
authors.initials: A
authors.lastname: Singla
authors.forename: Maria V
authors.initials: MV
authors.lastname: DeVita
authors.forename: Jordan L
authors.initials: JL
authors.lastname: Rosenstock
authors.forename: Michael F
authors.initials: MF
authors.lastname: Michelis
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003422:Critical Care; D005260:Female; D005440:Fluid Therapy / Q000379:methods*; D017052:Hospital Mortality; D006760:Hospitalization; D006801:Humans; D006955:Hypernatremia / Q000209:etiology / Q000401:mortality* / Q000628:therapy*; D007902:Length of Stay; D008297:Male; D009398:Nephrology; D009994:Osmolar Concentration; D012017:Referral and Consultation; D012189:Retrospective Studies; D012964:Sodium / Q000097:blood / Q000652:urine; D016896:Treatment Outcome
chemical_list: D012964:Sodium